mFluiDX

mFluiDx is a UC Berkeley spinout developing the SIMPLE CHIP, a low-cost point-of-care molecular diagnostic device that achieves PCR-equivalent sensitivity at the price of rapid antigen tests. The platform uses isothermal amplification and microfluidic technology to simultaneously detect multiple bacterial and viral pathogens from a single cartridge in 7–15 minutes, with fully automated sample-to-answer processing. Founded by Charlie Yeh (UCSF/UC Berkeley Joint PhD), the company is funded by NIH SBIR Phase I and Phase II grants, the Gates Foundation, and received seed funding through the IndieBio accelerator. It was a TechCrunch Battlefield finalist.